Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

30. Août 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3067


	Articles 1 - 20 / 61327

	Real-World-Feasible Immunohistochemistry of ATRX, DAXX, and Menin Identifies a Subgroup of Non-Functioning Pancreatic Neuroendocrine Tumors with low Recurrence Risk to Guide De-Escalating Surveillance. Endocr Pathol Verschuur AVD, Hackeng WM, Jairam J, Eldem B, Westendorp JS, Vriens MR, Valk GD, Pea A, Salvia R, Lawlor RT, Scarpa A, Luchini C, Heaphy CM, Hong SM, Marinoni I, Perren A, Dreijerink KMA, van Dijkum EJMN, Sarasqueta AF, Singhi AD, Elias SG, Brosens LAA. PMID: 42667492 [PubMed - indexed for MEDLINE]
	Precision immunotherapy in metastatic pancreatic cancer: OPTIMIZE-1 biomarker-driven patient stratification for future studies. Ann Pancreat Cancer Abdelhakeem A, Babiker HM. PMID: 42667071 [PubMed]
	Clinical Impact of the C-Reactive Protein-Albumin-Lymphocyte Index as a Prognostic Biomarker in Patients With Recurrent Pancreatic Cancer. In Vivo Sakamoto T, Urakami K, Uehira K, Yoshida J, Kishino M, Morimoto M, Murakami Y, Miyatani K, Shishido Y, Kihara K, Yamamoto M, Matsunaga T, Fujiwara Y. PMID: 42665404 [PubMed - indexed for MEDLINE]
	Perioperative Nutritional Changes Predict Adjuvant S-1 Dose Intensity in Resectable Pancreatic Cancer. In Vivo Suto H, Fujita AN, Sakai H, Muramatsu M, Wakamatsu R, Wakamatsu A, Katsuragawa M, Tanaya M, Hiura K. PMID: 42665382 [PubMed - indexed for MEDLINE]
	Intraductal papillary mucinous neoplasms: a comprehensive analysis combining genetic, immunopathological and clinical management. Curr Probl Cancer Izzo G, Tralongo P, Cerreto M, Ricciardi G, Ballato M, Giordano WG, Germanà E, Scarfì R, Ieni A, Zuccalà V, Fiorentino V, Carbone C, Martini M, Giuffrè G. PMID: 42664645 [PubMed - as supplied by publisher]
	Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study. Invest New Drugs Hatori M, Tsuji D, Nagai K, Arafune R, Yokokawa T, Kawakami K, Suzuki W, Shibata N, Sasahira N, Ozaka M, Yamaguchi M, Uchino T, Itoh K. PMID: 42663920 [PubMed - as supplied by publisher]
	Detection of Pancreatic Cancer via Specific Metabolite Markers: A Metabolomics Approach. Health Sci Rep Gourabi MJR, Ghafari M, Nikoo A, Saki YY, Khanbabaei B, Khanizadeh M, Kargar M, Hashemi A, Sharahi JY. PMID: 42661978 [PubMed]
	Dual-energy CT extracellular volume fraction for predicting the chemotherapeutic response in pancreatic ductal adenocarcinoma. Cancer Imaging Ming S, Cheng P, Ruan Y, Shi D, Wang B, Li J, Zhang W, Wang M, Zhu H, Zhang Y, Zhu C, Zhao B, Sun A, Wei W. PMID: 42661227 [PubMed - indexed for MEDLINE]
	Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma. Clin Exp Med Lu S, Ma J, Wang X, Zhang L, Lu J, Hu J. PMID: 42661129 [PubMed - indexed for MEDLINE]
	Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma. ESMO Open Tan CK, Vogel A, Wong YF, Ho GF, Zhou J, Atmakusuma TD, Kulkarni P, Kodama T, Chon HJ, Bello M, Yong WP, Hsu C, Korphaisarn K, Tanasanvimon S, Chen SC, Lee SY, Sebastian MR, Huh SJ, Morizane C, Tiwari P, Kalista KF, Qin S, Smyth EC, Lim E, Hou TC, Pentheroudakis G, Shan CW, André F, Muthukkumaran T, Ducreux M. PMID: 42660571 [PubMed - indexed for MEDLINE]
	Intraoperative esketamine for postoperative analgesia and depression in pancreatic cancer surgery: protocol for a multicenter randomized controlled trial. Ann Med Chong YZ, Sun YE, Ma X, Zhao HX, Zhang BY, Zhao QH, Yang MJ, Ji FH, Jiang L, Peng K. PMID: 42657795 [PubMed - indexed for MEDLINE]
	Case Report: A diagnostic dilemma: metachronous pancreatic metastasis from high-grade serous ovarian carcinoma. Front Oncol Baraka B, Al-Ani M, Afife A, Soomro I, Madhusudan S. PMID: 42656280 [PubMed]
	Utility of the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index in Prognostic Assessment of Pancreatic Head Adenocarcinomas Undergoing Pancreaticoduodenectomy. Medicina (Kaunas) I, Sar, Topal U, Ayd, Gümü, Yavuz B, Ülkü A, Akçam AT. PMID: 42654413 [PubMed - indexed for MEDLINE]
	Association Between Treatment-Emergent Pancreatic Volume Loss and Survival Outcomes in Patients with Metastatic Colorectal Cancer Receiving Bevacizumab. Medicina (Kaunas) Ayy, , Uyar GC, Çelik S, Karatl, Akgüner G, Turhan B, Duran Kaymak S, Kavak RP, . PMID: 42654356 [PubMed - indexed for MEDLINE]
	Immunomodulatory and Immunonutritional Effects of a Standardized Extract of Cultured Lentinula edodes Mycelia in Cancer: From Prevention to Perioperative Microenvironment Stabilization. Nutrients Nakatake R, Okuyama T, Adachi S, Matsu-Ura T, Kitade H, Nishizawa M. PMID: 42654311 [PubMed - indexed for MEDLINE]
	Association Between Dietary Total Fat and Cholesterol Intake and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Cohort and Case-Control Studies. Nutrients Ahmad SO, Umair M, Ali US, Hamza M, Kutbi E, Saleh SAK, Adly HM, Abu-Zaid A. PMID: 42654255 [PubMed - indexed for MEDLINE]
	MicroRNAs and Other Small RNAs in Liquid Biopsies as Biomarkers for Early Detection of Colorectal Cancer. Int J Mol Sci Navarro N, Gómez-Matas J, Di Battista C, Gironella M. PMID: 42653101 [PubMed - indexed for MEDLINE]
	From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models. Biomedicines Trachuk KN, Biryukova YK, Kapranov VA, Nazarenko AS, Orlova EA, Kozhemyakin GL, Demyashkin GA, Gordeychuk IV, Ishmukhametov AA, Kolyasnikova NM. PMID: 42652146 [PubMed]
	Metabolic Syndrome and Pancreatic Cancer: Linking Insulin Resistance, Inflammation, and Carcinogenesis. Diagnostics (Basel) Borbei R, Brata VD, Dobrot, Cetera, Clim M, Alexescu TG, Milaciu MV, Perne MG, Gerdanovics CA, Procopciuc LM, Cozma A, Or. PMID: 42651018 [PubMed]
	miRNA484 and miRNA335-5p as Potential Diagnostic Biomarkers for CA19-9-Negative Pancreatic Ductal Adenocarcinoma. Biomolecules Prado NO, Marin AM, Zem C, de Marchi M, Araújo DD, Alves MJF, Uno M, Chammas R, Zanette DL, Aoki MN. PMID: 42650826 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 61327

Page 1 de 3067



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité